Pricing new medicines in the UK: 'price is what you pay, value is what you get'?

Syrett, Keith 2012. Pricing new medicines in the UK: 'price is what you pay, value is what you get'? Law, Innovation and Technology 4 (2) , pp. 185-211. 10.5235/LIT.4.2.185

Full text not available from this repository.

Abstract

Warren Buffett's aphorism neatly captures the ambition underlying proposals which have been put forward for reform of regulation of pharmaceutical pricing in the UK's National Health Service. Through a critical evaluation of the envisioned system of 'value-based pricing', this article explores differing understandings of the value which a new medicine delivers to patients and society. It further considers the possible consequences for regulatory legitimacy of the adoption of the more pluralistic approach to value which the proposals embody.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Law
Subjects:	K Law > KD England and Wales R Medicine > RA Public aspects of medicine R Medicine > RM Therapeutics. Pharmacology
Publisher:	Hart Publishing
ISSN:	1757-9961
Last Modified:	04 Jun 2017 04:27
URI:	https://orca.cardiff.ac.uk/id/eprint/39442

Citation Data

Actions (repository staff only)

Edit Item